文献速递糖尿病肥胖与代谢综合征

应用机器学习预测伴或不伴代谢手术的2型糖尿病10年终末器官并发症风险

Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach.
PubMed 文献 · Diabetes Care · 2020-02-06

研究基于克利夫兰诊所健康系统1998至2017年接受代谢手术的2287例2型糖尿病患者,按1:5倾向性匹配11435例BMI≥30 kg/m2的常规治疗非手术患者,随访至2018年12月。构建多变量时间至事件回归和随机森林模型,采用五折交叉验证内部验证,预测四类结局10年风险,手术组与非手术组区分度分别为全因死亡0.79和0.81、冠状动脉事件0.66和0.67、心力衰竭0.73和0.75、肾病0.73和0.76。结论认为个体化糖尿病并发症风险评分可为患者和医生提供基于证据的风险信息。

要点

  • 代谢手术组与非手术组10年全因死亡预测AUC分别为0.79和0.81。
  • 冠状动脉事件预测AUC分别为0.66和0.67,心力衰竭为0.73和0.75。
  • 肾病预测AUC分别为0.73和0.76,模型已开发为网页和智能手机应用。

核心结论

  • 个体化糖尿病并发症风险评分可为2型糖尿病和肥胖患者提供基于其当前肥胖、糖尿病及相关心脏代谢状况的、关于未来心血管结局和死亡风险的个体化循证信息,并区分是否接受代谢手术。

研究设计与样本

  • 研究纳入1998至2017年在克利夫兰诊所健康系统接受代谢手术的2287例2型糖尿病患者,按1:5倾向性匹配11435例BMI≥30 kg/m2且接受常规治疗的2型糖尿病非手术患者,随访至2018年12月。
  • 构建多变量时间至事件回归和随机森林机器学习模型,采用五折交叉验证进行内部验证,预测四类结局的10年风险,并编程为网页和智能手机应用形式的个体化糖尿病并发症风险评分。

主要发现

  • 手术组与非手术组10年预测区分度(受试者工作特征曲线下面积,1为完美区分,0.5为随机)分别为:全因死亡0.79和0.81,冠状动脉事件0.66和0.67,心力衰竭0.73和0.75,肾病0.73和0.76。
  • 在个体化糖尿病并发症风险评分应用中输入患者数据后,可估算其接受与不接受代谢手术的个体化10年发病和死亡风险。

临床怎么用

  • 个体化糖尿病并发症风险评分可为考虑代谢手术的患者和执业者提供个体化循证风险信息,以辅助治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To construct and internally validate prediction models to estimate the risk of long-term end-organ complications and mortality in patients with type 2 diabetes and obesity that can be used to inform treatment decisions for patients and practitioners who are considering metabolic surgery. RESEARCH DESIGN AND METHODS: A total of 2,287 patients with type 2 diabetes who underwent metabolic surgery between 1998 and 2017 in the Cleveland Clinic Health System were propensity-matched 1:5 to 11,435 nonsurgical patients with BMI ≥30 kg/m2 and type 2 diabetes who received usual care with follow-up through December 2018. Multivariable time-to-event regression and random forest machine learning models were built and internally validated using fivefold cross-validation to predict the 10-year risk for four outcomes of interest. The prediction models were programmed to construct user-friendly web-based and smartphone applications of Individualized Diabetes Complications (IDC) Risk Scores for clinical use. RESULTS: The prediction tools demonstrated the following discrimination ability based on the area under the receiver operating characteristic curve (1 = perfect discrimination and 0.5 = chance) at 10 years in the surgical and nonsurgical groups, respectively: all-cause mortality (0.79 and 0.81), coronary artery events (0.66 and 0.67), heart failure (0.73 and 0.75), and nephropathy (0.73 and 0.76). When a patient's data are entered into the IDC application, it estimates the individualized 10-year morbidity and mortality risks with and without undergoing metabolic surgery. CONCLUSIONS: The IDC Risk Scores can provide personalized evidence-based risk information for patients with type 2 diabetes and obesity about future cardiovascular outcomes and mortality with and without metabolic surgery based on their current status of obesity, diabetes, and related cardiometabolic conditions.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Aminian A, Zajichek A, Arterburn DE, et al. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care. 2020. PMID: 32029638. doi:10.2337/dc19-2057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。